Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
Abroad (travel likely)Recruiting
Conditions
Stargardt-Like Macular Dystrophy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · prpl@cc.nih.gov · 800-411-1222
Study leads
Brett G Jeffrey, Ph.D.
Principal Investigator
National Eye Institute (NEI)